A real-world, nationwide, retrospective study of anti-TNFα drug dose escalation and drug sustainability in patient with Crohn's disease.
Latest Information Update: 05 Feb 2021
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary) ; Infliximab (Primary)
- Indications Crohn's disease
- Focus Adverse reactions; Therapeutic Use
- 05 Feb 2021 New trial record